C12Y 304/22063
Caspase-10
Official title: Caspase-10 (3.4.22.63)
C12Y304/22063 (Caspase-10) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 7
- Assignees
- 2
- Inventors
- 11
- Latest grant
- 2 Jun 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 2 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
By publication year.
Recent patents
- Cysteine reactive probes and uses thereof2 Jun 2020US 10,670,605 B2The Scripps Research Institute
- Method for the determination of botulinum neurotoxin biological activity15 Dec 2015US 9,212,355 B2MERZ PHARMA GmbH & CO. KGaA
- Method for the determination of botulinum neurotoxin biological activity4 Aug 2015US 9,096,886 B2MERZ PHARMA GmbH & CO. KGaA
- Lysine reactive probes and uses thereof19 Aug 2021US 2021/0255193 A1The Scripps Research Institute
- Cysteine reactive probes and uses thereof17 Sep 2020US 2020/0292555 A1The Scripps Research Institute
- Lysine reactive probes and uses thereof27 Dec 2018US 2018/0372751 A1The Scripps Research Institute
- Cysteine reactive probes and uses thereof27 Apr 2017US 2017/0115303 A1The Scripps Research Institute
- Method for the determination of botulinum neurotoxin biological activity8 Oct 2015US 2015/0284702 A1MERZ PHARMA GmbH & CO. KGaA
Most cited
By later US patents